CanSino Biologics (SHA:688185, HKG:6185) received a drug registration certificate for its ACYW135 Meningococcal Polysaccharide Conjugate Vaccine from Indonesia's drug regulator, a Monday bourse filing said.
The vaccine is indicated for the prevention of epidemic cerebrospinal meningitis in infants and children aged three months to three years.